1Y Close · As of Aug 26, 2026
BTB Korea operates in the Medical, Precision & Optical sector.
Legal name: BTB Korea Co.,Ltd
In fiscal year 2023, BTB Korea (219750) reported revenue of 2.7 billion KRW, down 52.4% from 5.7 billion KRW a year earlier.
Operating profit was -7.3 billion KRW and net income was -9.2 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 21.1 billion KRW, with a P/B of 0.87.
These figures can be verified in the DART filing (receipt no. 20260331003468).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2023 | 2.7B | -7.3B | -9.2B |
| 2022 | 5.7B | -7.6B | -12.8B |
| 2021 | 13.3B | -11.3B | -12.8B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |